Asset Details
Do you wish to reserve the book?
SER-109, an Oral Microbiome Therapy for Recurrent Clostridioides difficile Infection
Hey, we have placed the reservation for you!
By the way, why not check out events that you can attend while you pick your title.
Oops! Something went wrong.
Looks like we were not able to place the reservation. Kindly try again later.
Are you sure you want to remove the book from the shelf?
SER-109, an Oral Microbiome Therapy for Recurrent Clostridioides difficile Infection
Do you wish to request the book?
SER-109, an Oral Microbiome Therapy for Recurrent Clostridioides difficile Infection
Please be aware that the book you have requested cannot be checked out. If you would like to checkout this book, you can reserve another copy
We have requested the book for you!
Your request is successful and it will be processed during the Library working hours. Please check the status of your request in My Requests.
Oops! Something went wrong.
Looks like we were not able to place your request. Kindly try again later.
Journal Article
SER-109, an Oral Microbiome Therapy for Recurrent Clostridioides difficile Infection
2022
Overview
A major challenge with the treatment of
Clostridioides difficile
infection is restoring the antibiotic-associated alterations of bowel flora to a state less hospitable to
C. difficile
. In this trial, a microbiome-replacement therapy, SER-109, was used to treat patients with recurrent
C. difficile
infection and was shown to reduce the risk of further recurrence.
Publisher
Massachusetts Medical Society
Subject
